Portal Veterinary medicinal products

Changes in the amount of taxes and fees
20/01/2023
News

Changes in the amount of taxes and fees

As part of its tasks relating to the assessment and risk management of veterinary medicinal products, ANSES collects taxes and fees. The taxes, with the exception of the annual fee indexed to the turnover of veterinary medicinal products, are revalued annually. The services provided for in the ANSES catalogue are also upgraded.
Antimicrobial resistance in animal health: 2022 review
Antibiorésistance en santé animale et dans l’environnement
17/11/2022

Antimicrobial resistance in animal health: 2022 review

To mark World Antibiotic Awareness Week, ANSES is presenting its annual reports on sales of veterinary medicinal products and on the level of resistance of pathogenic bacteria in animals. It is also providing an update on its monitoring of resistance in bacteria that can contaminate humans via food of animal origin, conducted as part of monitoring plans that have been harmonised at European level.
Advertising for veterinary medicinal products — The fundamentals
moutons
29/09/2022
News

Advertising for veterinary medicinal products — The fundamentals

The provisions relating to the advertising of veterinary medicinal products are regulated by the European Regulation 2019/6 and supplemented, in France, by other obligations added in the Public Health Code (PHC). The main French provisions are as follows: Advertising for veterinary medicinal products may only be carried out by the marketing authorisation holder (MAH) of the medicinal products concerned by the advertisement or by the representative declared by the MAH in accordance with the provisions of Article L.5142-1.5 - I of the PHC. Only authorised veterinary medicinal products (marketing authorisation or parallel trade) or registered in France may be advertised in any form. Advertising in favour of veterinary medicinal products shall be authorised to physical person or legal entity authorised to issue them by Articles L. 5143-2 and L. 5143-6 of the PHC only for those whom they are authorised to prescribe or to issue. Public advertising is only possible for veterinary medicinal products not subject to veterinary prescription. Where medicinal products are being promoted to persons qualified to prescribe or supply them in accordance with the Regulation, no gifts, pecuniary advantages or benefit in kind may be supplied, offered or promised to such persons unless they are inexpensive and relevant to the practice of prescription or supply of medicinal products. All advertising materials must be submitted to Anses-ANMV for declaration or authorisation, at least 2 months prior to their dissemination (transmission of the projects to publicite-anmv@anses.fr ).
Franck Fourès appointed Director of the French Agency for Veterinary Medicinal Products
20/09/2022
News

Franck Fourès appointed Director of the French Agency for Veterinary Medicinal Products

Franck Fourès was appointed Director of the French Agency for Veterinary Medicinal Products, part of ANSES, by order of the Ministers of Agriculture and Health, on 29 July 2022. He will take up his new position on 1 November 2022.
Good practices in the use of veterinary medicines for pets
médicaments vétérinaires
28/07/2022

Good practices in the use of veterinary medicines for pets

Every year, many accidents are reported following the incorrect storage and use of veterinary medicines. In France, over 400 people were victims of this type of accident in 2020. While most reported cases are minor, more serious cases of poisoning can occur, particularly in young children.
Publication of the 2021 Activity Report on Veterinary Medicinal Products
Rapport d'activité
12/07/2022
News

Publication of the 2021 Activity Report on Veterinary Medicinal Products

This report takes stock of the activities of the French agency for veterinary medicinal products in 2021 with the highlights of the past year. It proposes a review of all the Agency’s actions in the field of veterinary medicinal products and details in particular the changes brought about by the entry into force of the Regulation on veterinary medicinal products. View the 2021 report for veterinary medicinal products (PDF)
To limit environmental exposure to antibiotics in veterinary medicine treatments
22/06/2022
News

To limit environmental exposure to antibiotics in veterinary medicine treatments

Many antibiotics are used in both humans and animals. As part of the One Health approach, the Veterinary Medicines Monitoring Committee, attached to the Director of Anses-ANMV, has just published an article on the impact of antibiotics on the environment.
Storage of veterinary medicines and recommendations during heatwaves
chaleur
21/06/2022
News

Storage of veterinary medicines and recommendations during heatwaves

Veterinary medicine quality is vital and must be ensured throughout the pharmaceutical chain, from design until use. Each participant in the chain has an influence on one or more parameters and needs to take precautions to guarantee and maintain veterinary medicine quality. During the summer, especially in cases of high heat, the storage of veterinary medicinal products may be affected; beyond 40 °C, there are risks of irreversible degradation (quality, effectiveness) or even toxicity (formation of degradation products).
Overview of the European conference on the use of plants in veterinary medicine
Phytothérapie Aromathérapie
20/05/2022
News

Overview of the European conference on the use of plants in veterinary medicine

The conference was organised in several sessions. In the first session, the context of the use of plants in veterinary medicine in the European Union was presented and the various stakeholders (farmers, veterinarians and pharmaceutical industries) were able to share their expectations and problems with the use of veterinary herbal medicines. Secondly, two experts from the Human Committee on Herbal Medicinal Products presented a feedback on the problems encountered in the authorisation of herbal medicinal products for human use compared to conventional chemical medicinal products. Then, the Anses-ANMV gave a feedback on the work carried out by France, in particular on the referral 2014-SA-0083 . Finally, these sessions continued with the presentation of the perspectives at European level by the EMA and the European Commission and the sharing of the views of the participants. Conference overview

Pages